Regentis Biomaterials Ltd (RGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,460 | -4,220 | -2,300 | -930 | -8,770 |
| Depreciation Amortization | 1,780 | 1,250 | 820 | 410 | 1,510 |
| Other Working Capital | 1,180 | 720 | 750 | 20 | 1,780 |
| Other Operating Activity | 460 | 410 | -160 | -60 | 730 |
| Operating Cash Flow | $-3,040 | $-1,840 | $-890 | $-560 | $-4,750 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -43,410 | -7,360 | -4,380 | -1,040 | -12,500 |
| Other Investing Activity | -220 | -30 | -40 | -30 | 580 |
| Investing Cash Flow | $-43,630 | $-7,390 | $-4,420 | $-1,070 | $-11,920 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | 0 | 0 | 0 | 0 | -600 |
| Other Financing Activity | 44,720 | 7,580 | 3,880 | 850 | 17,320 |
| Financing Cash Flow | $44,720 | $7,580 | $3,880 | $850 | $16,720 |
| Beginning Cash Position | 4,530 | 4,530 | 4,530 | 4,530 | 4,480 |
| End Cash Position | 2,580 | 2,880 | 3,100 | 3,740 | 4,530 |
| Net Cash Flow | $-1,950 | $-1,650 | $-1,430 | $-780 | $50 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,040 | -1,840 | -890 | -560 | -4,750 |
| Free Cash Flow | -3,040 | -1,840 | -890 | -560 | -4,750 |